Rituximab Treatment of Focal Segmental Glomerulosclerosis
Clinical trial NCT00550342 · WITHDRAWN
Trial details
- NCT number
- NCT00550342
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.